Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
532523
Company
Biocon Ltd
Exchange Received Time
03/08/2020 19:10:49
Exchange Disseminated Time
03/08/2020 19:10:57
Time Taken
00:00:08
Execution Of SHA And SSA With Tata Capital Growth Fund II - Disclosure Pursuant To Regulation 30 Of SEBI Regulations, 2015 |
08/03/20 19:10
Dear Sir/ Madam,
Further to our intimation dated July 31, 2020, in relation to the proposed primary equity investment by Tata Capital Growth Fund II ('Investor') in Biocon Biologics India Limited ('BBIL'), we further inform you that Biocon Limited (the 'Company'), BBIL and the Investor have executed a Share Subscription Agreement ('SSA') and the Company, BBIL, Activ Pine LLP ('Existing Investor') and the Investor have executed a Shareholders' Agreement ('SHA' and together with the SSA, the 'Transaction Documents').
This intimation is being made in compliance with Regulations 30, read with Schedule III and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time ('SEBI Listing Regulations') and the required disclosure is enclosed as Annexure A.
We request you to take this on record and that the same be treated as compliance under the applicable regulation(s).
Attachment
<< Back
Recently Viewed